We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 9 for:    chanques | France
Previous Study | Return to List | Next Study

Electronic Distraction for ICU Patients (CHOISIR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04017299
Recruitment Status : Completed
First Posted : July 12, 2019
Last Update Posted : July 10, 2020
Sponsor:
Information provided by (Responsible Party):
University Hospital, Montpellier

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This is a feasibility study of electronic devices in order to reduce neuro-psychological disorders and suffering in intensive care unit (ICU) patients. A first step study is necessary to define which device is effective and safe to reduce symptom intensities, among music therapy, virtual reality with real pictures, virtual reality with artificial pictures, and common devices (radio or television). If some devices are effective to reduce patients' symptoms, a second step will be to implement and assess the impact of these tools in a multicenter trial.

Condition or disease Intervention/treatment Phase
Adult ICU Patients Other: CHOISIR Not Applicable

Detailed Description:
Quality of life following intensive care unit discharge is more and more anticipated during the ICU stay. Psychological trauma during ICU stay, related to medical management, can be very deleterious at short and long term, inducing psychological troubles as post-traumatic stress disorder and delaying the return to a normal social and professional life. For this reason, managing patients' distress is particularly important in the intensive care setting. There has been an increasing number of new technologies for the distraction of patients in different settings. a Today, a large amount of electronic distraction is available. TV and radio are available in each ICU, music therapy has already been studied and it is currently used in some ICUs. Virtual reality (VR) is used to improve attention and memory in stroke patients. Furthermore, VR seems to decrease stress post trauma disorders and phobia, as well as pain and anxiety during surgical procedures and physiotherapy. Our first step study will help us to determine which electronic distraction has the most effect on the top five discomfort symptoms frequently observed in ICU: pain, anxiety dyspnea, thirst and sleep privation.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Choose an Electronic Distraction, Faisability and Discomfort Improvement Evaluation by and for ICU Patients : a Cross Over Randomized Controlled Study.
Actual Study Start Date : July 17, 2019
Actual Primary Completion Date : December 31, 2019
Actual Study Completion Date : December 31, 2019

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Active Comparator: Virtual reality with computer graphics
Use of Virtual reality with computer graphics
 Other: CHOISIR
Every patient will evaluate each device after 15 minutes of distraction once or twice a day according to the patient's wishes.
Active Comparator: Virtual reality with real movies
Use of Virtual reality with real movies
 Other: CHOISIR
Every patient will evaluate each device after 15 minutes of distraction once or twice a day according to the patient's wishes.
Active Comparator: Music therapy (dedicated device and music scores)
Use of music therapy (dedicated device and music scores)
 Other: CHOISIR
Every patient will evaluate each device after 15 minutes of distraction once or twice a day according to the patient's wishes.
Usual device (TV radio)
usual distraction : watching TV
 Other: CHOISIR
Every patient will evaluate each device after 15 minutes of distraction once or twice a day according to the patient's wishes.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Variation of intensity of the 5 discomfort symptoms (pain, anxiety, thirst, dyspnea, insomnia) assessed by a self-report 0-10 visually enlarged numeric rating scale [ Time Frame: Just after the use of each device (up to 20 minutes) ]

Secondary Outcome Measures :
  1. Variation of physiologic parametres (Heart Rate, Blood pressure, Respiratory rate and Analgesia nociception Index), evaluation of feasibility and feelings concerning the distraction devices. [ Time Frame: ICU discharge (up to Day 28) ]
  2. Variation of Respiratory rate during the use of each device [ Time Frame: up to 20 minutes (after the device use ) ]
    Respiratory rate : c/min

  3. Variation of physiologic Blood pressure during the use of each device [ Time Frame: up to 20 minutes (after the device use ) ]
    Blood pressure : mmHg

  4. Variation of Heart Rate during the use of each device [ Time Frame: up to 20 minutes (after the device use ) ]
    Heart Rate : b/min

  5. evaluation of feasibility assessed by the Numeric Rating Scale from 0 to 10 [ Time Frame: just after the use of each device (up to 20 minutes) ]
    Numeric Rating Scale from 0 to 10

  6. Evaluation of the feelings concerning the distraction devices assessed by the Numeric Rating Scale from 0 to 10 [ Time Frame: ICU discharge or up to Day 28 ]
    Numeric Rating Scale from 0 to 10


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patient admitted in intensive care unit,
  • adult,
  • French speaking,
  • awake (RASS ≥ -1),
  • not delirious (CAM-ICU negative),

Exclusion Criteria:

  • patient refusal
  • psychosis or preexisting cognitive dysfunction
  • cerebral injury,
  • hygiene/microbiological harm,
  • pregnancy,
  • decision of withdrawal of care
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04017299


Locations
Layout table for location information
France
University of Montpellier Hospital
Montpellier, France, 34295
Sponsors and Collaborators
University Hospital, Montpellier
Investigators
Layout table for investigator information
Principal Investigator: Gérald CHANQUES, PhD University of Montpellier Hospitals
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: University Hospital, Montpellier
ClinicalTrials.gov Identifier: NCT04017299    
Other Study ID Numbers: 7667
First Posted: July 12, 2019    Key Record Dates
Last Update Posted: July 10, 2020
Last Verified: July 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: identified data used in the published manuscript will be shared in accordance with the applicable informed consent under which the data was collected
Time Frame: 12 months after the main publication
Access Criteria: Data are provided to qualified investigators free of charge. Required documents to request data include a summary of the research plan, request form, and IRB review. Dataset will be shared after careful examination by the study board of investigators.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Montpellier:
ICU
Pain
Anxiety
Thirst
Dyspnea
 Sleep
Discomfort
Distress
Virtual Reality
Music Therapy